AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,000 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $1,000 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $1,000 | – | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |